ABSTRACT
Fact Sheet for Healthcare Providers: LumiraDx UK Ltd.; LumiraDx SARS-CoV-2 Antigen (Ag) Test [open pdf - 142KB]
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the LumiraDx SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Antigen (Ag) Test. The LumiraDx SARS-CoV-2 Ag Test is authorized for use using nasal swab specimens collected from individuals who are suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider within the first twelve days of the onset of symptoms."
| Publisher: | |
| Date: | 2020-08-18 |
| Series: | |
| Copyright: | Public Domain |
| Retrieved From: | U.S. Food and Drug Administration: https://www.fda.gov/ |
| Format: | pdf |
| Media Type: | application/pdf |
| URL: |